Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 3/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7979506 | 0.99 | ABCB1 (0.52) | ABCB1ABCG2KDM4EHSD17B10MAPT | |
| Bromide SCHEMBL8218997 | 0.90 | HTR7 (0.43) | ABCB1ABCG2KDM4EALDH1A1DRD4 | |
| Bromide SCHEMBL7991351 | 0.89 | LMNA (0.41) | ABCB1ABCG2MAPTGAALMNA | |
| SCHEMBL7997014 | 0.89 | HTR7 (0.44) | ABCB1ABCG2KDM4EALDH1A1DRD4 | |
| SCHEMBL7993833 | 0.88 | LMNA (0.41) | ABCB1ABCG2MAPTGAALMNA | |
| Bromide SCHEMBL7993358 | 0.87 | DRD2 (0.43) | KDM4EGAADRD4DRD3DRD2 | |
| SCHEMBL7991687 | 0.86 | DRD2 (0.43) | KDM4EGAADRD4DRD3DRD2 | |
| SCHEMBL7996949 | 0.86 | PTK2 (0.47) | KDM4EMAPTALDH1A1GAALMNA | |
| Bromide SCHEMBL7996854 | 0.85 | DRD2 (0.45) | ABCB1ABCG2KDM4EMAPTALDH1A1 | |
| SCHEMBL7990254 | 0.85 | KDM4E (0.41) | KDM4EMAPTALDH1A1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6288230-B1 | COMPOUNDS FOR TREATMENT OF PSYCHOLOGICAL DISORDERS | NEUROGEN CORPORATION | 2001-09-11 | — | — | US | disclosed |
| WO-2000018763-A2 | 2-(2,3-DIHYDROBENZOFURAN-5-YL)-4-AMINOMETHYLIMIDAZOLES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 2000-04-06 | — | — | WO | disclosed |